Filter
386
Filtered Results: 386
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
42
New Publications
124
Language
Document type
No document type
204
Guidelines
64
Studies & Reports
51
Strategic & Response Plan
27
Manuals
23
Fact sheets
7
Training Material
6
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
21
Ghana
16
Uganda
16
Nigeria
15
Global
15
India
15
Western and Central Europe
13
Namibia
12
Rwanda
11
Eastern Europe
11
Nepal
10
South Africa
10
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Zambia
5
Liberia
5
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Guinea
2
Africa
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Vietnam
1
Sri Lanka
1
Yemen
1
Georgia
1
Central African Republic
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
200
Clinical Guidelines
41
Public Health
9
Capacity Building
6
Women & Child Health
6
Key Resources
5
Pharmacy & Technologies
5
Toolboxes
TB
45
Pharmacy
39
AMR
32
Malaria
27
COVID-19
23
HIV
18
NTDs
15
NCDs
4
Ebola & Marburg
3
Specific Hazards
2
Refugee
2
Caregiver
2
Planetary Health
2
Rapid Response
1
Cholera
1
Polio
1
Global Health Education
1
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approac...
8–18 December 2015
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Annual Report: 2015-2016
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb...
Le Plan Stratégique National de Lutte contre le Paludisme 2023–2027 de la Guinée vise à réduire de 80 % l’incidence et la mortalité liées au paludisme d’ici 2027, en s’appuyant sur les leçons des années précédentes. Il prévoit des actions renforcées de prévention (moustiquaire...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action ...
The goals and objectives of the Sudan National Action Plan on AMR can only be achieved through implementing strategic interventions and activities with all concerned ministries and departments joining hands with other stakeholders to collaboratively tackle these challenges.
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
